Pharmacologic inhibition of YTHDC1 biomolecular condensates as a novel approach to targeting L-MYC driven small cell lung cancerEUROPEAN JOURNAL OF CANCERIF7.12024-10-010PRE
Microfluidics-based screening platform identifies a novel therapeutic approach to targeting EML4-ALK driven cancersCANCER RESEARCHIF16.62024-03-220PRE
Discovery of novel biomolecular condensate drug targets in oncology using in silico predictive toolsCANCER RESEARCHIF16.62024-03-220PRE
Pharmacological inhibition of the m6A RNA reader, YTHDC1, as a novel approach to targeting biomolecular condensates in cancerCANCER RESEARCHIF16.62024-03-221PRE
The 2021 FASEB Virtual Catalyst Conference on Imaging Cells to Organisms for Basic Science and Medical Research, April 14, 2021FASEB JOURNALIF4.22021-06-181PRE
Musculoskeletal problems in bricklayers as a function of length of employment: The role of secondary selection by low-back painWORK AND STRESSIF62007-09-259PREAI